Corneal Cross-Linking and Early Intervention

One of the Academy’s primary educational priorities is advancing the understanding and appropriate clinical application of corneal cross-linking. IKA has championed the paradigm shift from the historical practice of observing patients for documented disease progression before treatment to a modern approach centered on early diagnosis and intervention before irreversible structural damage and vision loss occur. The Academy promotes evidence-based treatment algorithms that incorporate corneal cross-linking at the earliest appropriate stage of disease to preserve vision and reduce the long-term need for corneal transplantation.

Research and Scientific Advancement

IKA supports clinical, translational, and outcomes-based research that advances the understanding of corneal ectatic disease and improves patient care. The Academy encourages multidisciplinary collaboration and serves as a forum for the development and dissemination of scientific evidence that informs clinical practice, identifies emerging technologies, and promotes innovation in diagnosis and treatment.

Pediatric Keratoconus Initiative

Recognizing that keratoconus in children is frequently more aggressive and progresses more rapidly than in adults, IKA has placed particular emphasis on early identification and treatment in pediatric patients.